Allworth Financial’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35	Hold	22	–	–	﹤0.01%	5096
2025 Q4	$37	Sell	22 -9,983	-100%	-$17.3K	﹤0.01%	4868
2025 Q3	$16.9K	Hold	10,005	–	–	﹤0.01%	2808
2025 Q2	$9.08K	Hold	10,005	–	–	﹤0.01%	2943
2025 Q1	$4.99K	Hold	10,005	–	–	﹤0.01%	2762
2024 Q4	$6.75K	Sell	10,005 -4,750	-32%	-$3.49K	﹤0.01%	2618
2024 Q3	$13.4K	Buy	14,755 +10,000	+210%	+$9.27K	﹤0.01%	2129
2024 Q2	$4.75K	Hold	4,755	–	–	﹤0.01%	2551
2024 Q1	$7.04K	Buy	4,755 +5	+0.1%	+$6	﹤0.01%	2258
2023 Q4	$5.18K	Hold	4,750	–	–	﹤0.01%	2262
2023 Q3	$5.61K	Hold	4,750	–	–	﹤0.01%	2057
2023 Q2	$6.7K	Hold	4,750	–	–	﹤0.01%	1989
2023 Q1	$7.13K	Hold	4,750	–	–	﹤0.01%	1909
2022 Q4	$5.56K	Hold	4,750	–	–	﹤0.01%	1857
2022 Q3	$5K	Hold	4,750	–	–	﹤0.01%	1884
2022 Q2	$8K	Hold	4,750	–	–	﹤0.01%	1634
2022 Q1	$7K	Hold	4,750	–	–	﹤0.01%	1567
2021 Q4	$12K	Hold	4,750	–	–	﹤0.01%	1324
2021 Q3	$12K	Hold	4,750	–	–	﹤0.01%	1227
2021 Q2	$14K	Buy	+4,750	New	+$12.3K	﹤0.01%	945

Other funds holding LCTX